Opportunity Information: Apply for RFA CA 22 027
The National Institutes of Health (NIH) released this discretionary grant opportunity, RFA-CA-22-027, titled "Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)." It uses the R01 grant mechanism and supports projects in the broad areas of education and health (CFDA 93.395, 93.396, 93.397, 93.398). The core focus is on people living with advanced cancers that are likely incurable, recognizing that many patients are surviving longer with serious disease and have distinct, often under-studied survivorship needs. The FOA seeks to strengthen the evidence base on what these needs are, how widespread they are, and what approaches can effectively improve quality of life and other patient-centered outcomes.
The purpose of the announcement is twofold: first, to fund observational research that clarifies the scope, prevalence, and nature of survivorship challenges among individuals living with advanced cancer; and second, to fund intervention research that develops and tests strategies to address those challenges. In practice, this means the NIH is looking for studies that can describe and measure survivorship needs (for example, physical symptoms, psychological distress, social and family impacts, financial toxicity, functional limitations, care coordination needs, or communication and decision-support gaps) as well as studies that create or evaluate programs, services, or clinical approaches intended to improve outcomes for these survivors. Because the FOA is labeled "Clinical Trial Optional," applicants may propose either non-trial research (such as cohort studies, longitudinal assessments, mixed-methods studies, or other observational designs) or clinical trials (such as testing a supportive care intervention, service delivery model, symptom management approach, or psychosocial program), as long as the work is clearly tied to survivorship in advanced cancer and is appropriately designed for the question being asked.
Funding under this opportunity has an award ceiling listed at $500,000, indicating an upper bound on the amount that can be requested or awarded under the terms of this specific announcement. The original closing date shown is 2023-09-29, and prospective applicants would typically need to confirm whether the announcement is still active, has been reissued, or has moved to a new due date or related FOA if applying later. The overall intent is to stimulate research that translates into practical improvements in care and support for people living with advanced cancer, rather than focusing solely on cure-oriented endpoints.
Eligibility is broad and includes many common applicant types across government, education, nonprofit, and industry. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and other categories specified in the notice. The FOA explicitly highlights additional eligible applicant groups such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, faith-based or community-based organizations, regional organizations, and U.S. territories or possessions. These inclusions signal an interest in reaching diverse communities and encouraging proposals that can address survivorship needs across different populations and settings.
At the same time, the FOA draws clear boundaries around foreign participation. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) entities (foreign institutions) are stated as not eligible to apply as applicant organizations. In addition, non-domestic components of U.S. organizations are not eligible to apply as part of the applicant organization. However, "foreign components," as defined in the NIH Grants Policy Statement, are allowed, meaning a U.S.-based applicant may incorporate certain allowable international elements or collaborations if they meet NIH definitions and requirements, even though a foreign institution cannot serve as the primary applicant.
In summary, this NIH R01 opportunity is aimed at building a clearer, more actionable understanding of survivorship for individuals living with advanced, likely incurable cancers and supporting research that can directly improve their outcomes. It encourages both observational studies that map unmet needs and interventional studies that test solutions, welcomes a wide variety of U.S.-based applicants across academic, community, government, nonprofit, and for-profit sectors, and permits limited foreign components while restricting foreign entities from serving as applicants.Apply for RFA CA 22 027
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Research to Understand and Address the Survivorship Needs of Individuals Living with Advanced Cancer (R01 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.395, 93.396, 93.397, 93.398.
- This funding opportunity was created on 2022-05-12.
- Applicants must submit their applications by 2023-09-29. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)
Previous opportunity: NIJ FY22 Evaluation of OJP Community Based Violence Intervention and Prevention Initiative (CVIPI) Projects
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA CA 22 027
Applicants also applied for:
Applicants who have applied for this opportunity (RFA CA 22 027) also looked into and applied for these:
| Funding Opportunity |
|---|
| Workshops on Computational and Analytical Research Methods (R25 - Clinical Trial Not Allowed) Apply for RFA DA 23 027 Funding Number: RFA DA 23 027 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Stimulants and HIV: Addressing Contemporary and Recurring Epidemics (R61/R33 - Clinical Trial Required) Apply for RFA DA 23 008 Funding Number: RFA DA 23 008 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| Treatments for Lewy Body Dementias and Frontotemporal Dementias--Exploratory Clinical Trial (U01 Clinical Trial Required) Apply for RFA NS 22 056 Funding Number: RFA NS 22 056 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 187 Funding Number: PAR 22 187 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 22 188 Funding Number: PAR 22 188 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| A Multi-omics Approach to Immune Responses in HIV Vaccination and Intervention (P01 Clinical Trial Not Allowed) Apply for RFA AI 22 038 Funding Number: RFA AI 22 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,000,000 |
| Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed) Apply for RFA DA 23 015 Funding Number: RFA DA 23 015 Agency: National Institutes of Health Category: Education, Health Funding Amount: $350,000 |
| Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) Apply for PAR 22 181 Funding Number: PAR 22 181 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R43/R44 Clinical Trial Optional) Apply for RFA DA 23 020 Funding Number: RFA DA 23 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Novel Drug (DDT) and Medical Device Development Tools (MDDT) to Help Expedite Creation and Regulatory Approvals of New Therapies for Substance Use Disorders (SUD) (R41/R42 Clinical Trial Optional) Apply for RFA DA 23 019 Funding Number: RFA DA 23 019 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Apply for PAR 22 165 Funding Number: PAR 22 165 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Apply for PAR 22 164 Funding Number: PAR 22 164 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, R01 Clinical Trial Optional) Apply for PAR 22 198 Funding Number: PAR 22 198 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Limited Competition: A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 22 026 Funding Number: RFA CA 22 026 Agency: National Institutes of Health Category: Education, Health Funding Amount: $5,500,000 |
| Precision Approaches in Radiation Synthetic Combinations (PAIRS, R21 Clinical Trial Optional) Apply for PAR 22 199 Funding Number: PAR 22 199 Agency: National Institutes of Health Category: Education, Health Funding Amount: $275,000 |
| Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 Clinical Trial Not Allowed) Apply for RFA DA 23 052 Funding Number: RFA DA 23 052 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Registry of Medical Cannabis Use and Health Outcomes (UM1 - Clinical Trial Optional) Apply for RFA DA 23 011 Funding Number: RFA DA 23 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: $1,500,000 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) Apply for PAR 22 173 Funding Number: PAR 22 173 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) Apply for PAR 22 174 Funding Number: PAR 22 174 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Therapeutic Development of Psychoplastogenic Compounds for Substance Use Disorders (R43/R44 - Clinical Trials Not Allowed) Apply for RFA DA 23 017 Funding Number: RFA DA 23 017 Agency: National Institutes of Health Category: Education, Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA CA 22 027", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
